New agreement enables both companies to fuel a broad and innovative pipeline of 212Pb-Radio-DARPin candidates, bringing the total number of ...

Iktos, a leader in Artificial Intelligence (AI) and Robotics for drug design, and Cube Biotech, a pioneer in membrane protein production and purification technologies, today announced a strategic ...

Over a video call, Alex Zhavoronkov holds up a small, green, diamond-shaped pill. It has been developed by his company to ...

Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, and Owkin, a TechBio that uses agentic AI to unlock complex targets for drug discovery, development, and diagnostics ...

The opening of the UK’s first safer drugs consumption room will be a “significant step forward” in efforts to tackle Scotland’s drug problem, John Swinney has said. The First Minister was speaking as ...

Chinese health and wellness startups have showcased innovative products ranging from AI-enabled smart rings to innovative ...

RiDYMO® has been successfully employed in various drug discovery programs, including the development of small molecule ...

Ebola virus, one of the deadliest pathogens, has a fatality rate of about 50%, posing a serious threat to global health and ...

With multiple stakeholders involved with different interests, the “specialty drug” definition can be a moving target.

By combining diverse datasets and powerful analytical and modeling tools, drug developers are finding more potential ...

Insilico Medicine (‘Insilico’), a clinical-stage generative artificial intelligence (AI)-driven drug discovery and ...

The starting point for all structure-based design work, whether ligand or protein based, is the choice of a suitable target. Antimicrobial-drug targets should be essential, have a unique function ...